RWANDA BIOMEDICAL CENTRE

The Sabin Vaccine Institute has initiated a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, building on ongoing trials in Kenya and Uganda.

Rwanda is intensifying measures against a Rift Valley Fever (RVF) outbreak following a recent resurgence near the Tanzanian border, raising concerns about potential human transmission.